BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 11, 2011
View Archived Issues
TopoTarget patents new NAmPRTase inhibitors
Read More
Cellzome discloses novel tyrosine-protein kinase ZAP-70 inhibitors
Read More
Abraxis claims new proto-oncogene tyrosine-protein kinase Src inhibitors
Read More
New inhibitors claimed of DNA gyrase and/or DNA topoisomerase 4
Read More
Anticocaine vaccine dAd5GNC shows promise in mice
Read More
Methylation of FMR1 promoter may predict response to AF-Q056 in fragile X syndrome
Read More
GSK discloses new lysophospholipid S1P1 receptor agonists
Read More
Merck & Co. patents new Egl nine homolog inhibitors
Read More
Amgen grants MedImmune rights to develop AMG-108 worldwide outside Japan
Read More
Profectus' multiantigen HIV pDNA vaccine enters phase I trial
Read More
ATX-101 enters European phase III trials for reduction of submental fat
Read More
Bristol-Myers Squibb and AstraZeneca launch Kombiglyze in U.S.
Read More
Eusa Pharma obtains FDA priority review status for Erwinaze BLA
Read More
FDA approves Abstral for breakthrough cancer pain
Read More
EMA and FDA grant expedited review for boceprevir
Read More
Rivaroxaban filed for approval in E.U. and U.S. for stroke prevention and other indications
Read More
Enrollment begins in phase III regorafenib trial in gastrointestinal stromal tumors
Read More
New indication for Lucentis in E.U. for vision loss in diabetic macular edema
Read More
EB-1010 improves symptoms of major depressive disorder
Read More
Forest Laboratories launches Teflaro in U.S.
Read More
Inhibitex reports interim safety and antiviral data from phase Ib INX-189 trial
Read More
ELN-457946 reduces restenosis in porcine model combining endothelial denudation and stent placement
Read More
Acceleron receives grant to develop ACE-031 for DMD
Read More
Sandoz initiates phase II trial of its biosimilar rituximab
Read More
Lexicon reports phase II data on LX-4211 in type 2 diabetes
Read More